Newsletter

476830 - Rznomics, Inc.

476830 Summary

Biopharma

Stock Price & Overview

₩28,750 -200 (-0.69%) Close · Sep 9, 2026 KST

KOSDAQ | ₩KRW | Close: ₩28,750 ≈ US$21 · Market cap ₩0.8tn (≈ $576m)

Home › 476830 › Filings

5% Ownership Report — Short Form

DART

Rznomics, Inc.

Filed Sep 9, 2026 KST · Ownership · receipt 20260909000435

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.

Korean form name: 주식등의대량보유상황보고서(약식)

476830

Price: ₩28,750
Change: -0.69%
Market cap: ₩0.8tn
Prev. close: ₩28,950

476830 Summary Compare to Peers

476830 data on kstock

Financials: 11 fiscal years
Valuation: Daily P/E, P/S, P/B, P/CF
Earnings: Eight quarters
Dividends: Per-share history

Every figure is taken from Rznomics, Inc.'s own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

More 476830 filings

476830 - Rznomics, Inc.

5% Ownership Report — Short Form

476830

476830 data on kstock

More 476830 filings

Investor Relations Event

Half-Year Report

Insider / Major Shareholder Holdings Report

Insider / Major Shareholder Holdings Report ×4

5% Ownership Report — Large Holdings

5% Ownership Report — Short Form